{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:26:02Z","timestamp":1790803562751,"version":"4.1.0"},"reference-count":210,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014331","name":"Motor Neurone Disease Australia","doi-asserted-by":"publisher","award":["1950"],"award-info":[{"award-number":["1950"]}],"id":[{"id":"10.13039\/100014331","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Andrew Butcher Grant","award":["1950"],"award-info":[{"award-number":["1950"]}]},{"DOI":"10.13039\/501100001785","name":"Flinders University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001785","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is a progressive neurological disorder, characterised by the death of upper and lower motor neurons. The aetiology of ALS remains unknown, and treatment options are limited. Endogenous retroviruses (ERVs), specifically human endogenous retrovirus type K (HERV-K), have been proposed to be involved in the propagation of neurodegeneration in ALS. ERVs are genomic remnants of ancient viral infection events, with most being inactive and not retaining the capacity to encode a fully infectious virus. However, some ERVs retain the ability to be activated and transcribed, and ERV transcripts have been found to be elevated within the brain tissue of MND patients. A hallmark of ALS pathology is altered localisation of the transactive response (TAR) DNA binding protein 43\u00a0kDa (TDP-43), which is normally found within the nucleus of neuronal and glial cells and is involved in RNA regulation. In ALS, TDP-43 aggregates within the cytoplasm and facilitates neurodegeneration. The involvement of ERVs in ALS pathology is thought to occur through TDP-43 and neuroinflammatory mediators. In this review, the proposed involvement of TDP-43, HERV-K and immune regulators on the onset and progression of ALS will be discussed. Furthermore, the evidence supporting a therapy based on targeting ERVs in ALS will be reviewed.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s12035-023-03472-y","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T03:02:11Z","timestamp":1689303731000},"page":"6330-6345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Molecular Link Between TDP-43, Endogenous Retroviruses and Inflammatory Neurodegeneration in Amyotrophic Lateral Sclerosis: a Potential Target for Triumeq, an Antiretroviral Therapy"],"prefix":"10.1007","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0146-4814","authenticated-orcid":false,"given":"Megan","family":"Dubowsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Theunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian M.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Louise","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"issue":"2","key":"3472_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nrneurol.2014.250","volume":"11","author":"A Chi\u00f2","year":"2015","unstructured":"Chi\u00f2 A, Traynor BJ (2015) Motor neuron disease in 2014: biomarkers for ALS\u2013in search of the promised land. Nat Rev Neurol 11(2):72","journal-title":"Nat Rev Neurol"},{"key":"3472_CR2","unstructured":"Foster LA, Salajegheh MK (2018) Motor neuron disease: pathophysiology, diagnosis, and management. Am J Med"},{"issue":"2","key":"3472_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrneurol.2017.186","volume":"14","author":"MC Kiernan","year":"2018","unstructured":"Kiernan MC (2018) Motor neuron disease in 2017: progress towards therapy in motor neuron disease. Nat Rev Neurol 14(2):65","journal-title":"Nat Rev Neurol"},{"issue":"7\u20138","key":"3472_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/21678421.2020.1779298","volume":"21","author":"C Bendotti","year":"2020","unstructured":"Bendotti C, Bonetto V, Pupillo E, Logroscino G, Al-Chalabi A, Lunetta C et al (2020) Focus on the heterogeneity of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21(7\u20138):485\u2013495","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"issue":"11","key":"3472_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrneurol.2011.153","volume":"7","author":"O Hardiman","year":"2011","unstructured":"Hardiman O, Van Den Berg LH, Kiernan MC (2011) Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol 7(11):639","journal-title":"Nat Rev Neurol"},{"issue":"5\u20136","key":"3472_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/17482960802566824","volume":"10","author":"A Chio","year":"2009","unstructured":"Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E et al (2009) Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 10(5\u20136):310\u2013323","journal-title":"Amyotroph Lateral Scler"},{"issue":"5","key":"3472_CR7","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","volume":"32","author":"E Longinetti","year":"2019","unstructured":"Longinetti E, Fang F (2019) Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol 32(5):771\u2013776","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"3472_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2353\/ajpath.2007.070182","volume":"171","author":"NJ Cairns","year":"2007","unstructured":"Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ et al (2007) TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 171(1):227\u2013240","journal-title":"Am J Pathol"},{"issue":"5","key":"3472_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ana.21147","volume":"61","author":"IR Mackenzie","year":"2007","unstructured":"Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ et al (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol: Official Journal of the American Neurological Association and the Child Neurology Society 61(5):427\u2013434","journal-title":"Ann Neurol: Official Journal of the American Neurological Association and the Child Neurology Society"},{"issue":"5796","key":"3472_CR10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(5796):130\u2013133","journal-title":"Science"},{"key":"3472_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mcn.2017.07.001","volume":"83","author":"L Heyburn","year":"2017","unstructured":"Heyburn L, Moussa CEH (2017) TDP-43 in the spectrum of MND-FTLD pathologies. Mol Cell Neurosci 83:46\u201354","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"3472_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/jnc.14327","volume":"146","author":"J Gao","year":"2018","unstructured":"Gao J, Wang L, Huntley ML, Perry G, Wang X (2018) Pathomechanisms of TDP-43 in neurodegeneration. J Neurochem 146(1):7\u201320","journal-title":"J Neurochem"},{"issue":"5","key":"3472_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.2533\/chimia.2019.380","volume":"73","author":"T Afroz","year":"2019","unstructured":"Afroz T, Perez-Berlanga M, Polymenidou M (2019) Structural transition, function and dysfunction of TDP-43 in neurodegenerative diseases. CHIMIA Int J Chem 73(5):380\u2013390","journal-title":"CHIMIA Int J Chem"},{"issue":"2","key":"3472_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1474-4422(18)30394-6","volume":"18","author":"DR Beers","year":"2019","unstructured":"Beers DR, Appel SH (2019) Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol 18(2):211\u2013220","journal-title":"Lancet Neurol"},{"issue":"5","key":"3472_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1474-4422(21)00414-2","volume":"21","author":"SA Goutman","year":"2022","unstructured":"Goutman SA, Hardiman O, Al-Chalabi A, Chi\u00f3 A, Savelieff MG, Kiernan MC et al (2022) Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol 21(5):465\u2013479","journal-title":"Lancet Neurol"},{"key":"3472_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fneur.2020.00279","volume":"11","author":"PA McCombe","year":"2020","unstructured":"McCombe PA, Lee JD, Woodruff TM, Henderson RD (2020) The peripheral immune system and amyotrophic lateral sclerosis. Front Neurol 11:279","journal-title":"Front Neurol"},{"issue":"1","key":"3472_CR17","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.1038\/s41598-017-09097-1","volume":"7","author":"Y Hu","year":"2017","unstructured":"Hu Y, Cao C, Qin X-Y, Yu Y, Yuan J, Zhao Y et al (2017) Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study. Sci Rep 7(1):9094","journal-title":"Sci Rep"},{"issue":"4","key":"3472_CR18","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s13311-022-01233-8","volume":"19","author":"W Li","year":"2022","unstructured":"Li W, Pandya D, Pasternack N, Garcia-Montojo M, Henderson L, Kozak CA et al (2022) Retroviral elements in pathophysiology and as therapeutic targets for amyotrophic lateral sclerosis. Neurotherapeutics 19(4):1085\u20131101","journal-title":"Neurotherapeutics"},{"issue":"6","key":"3472_CR19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1080\/1040841X.2018.1501345","volume":"44","author":"M Garcia-Montojo","year":"2018","unstructured":"Garcia-Montojo M, Doucet-O\u2019Hare T, Henderson L, Nath A (2018) Human endogenous retrovirus-K (HML-2): a comprehensive review. Crit Rev Microbiol 44(6):715\u201338","journal-title":"Crit Rev Microbiol"},{"issue":"6","key":"3472_CR20","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1073\/pnas.0307885100","volume":"101","author":"JF Hughes","year":"2004","unstructured":"Hughes JF, Coffin JM (2004) Human endogenous retrovirus K solo-LTR formation and insertional polymorphisms: implications for human and viral evolution. Proc Natl Acad Sci 101(6):1668\u20131672","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"3472_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/ana.22149","volume":"69","author":"R Douville","year":"2011","unstructured":"Douville R, Liu J, Rothstein J, Nath A (2011) Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Ann Neurol 69(1):141\u2013151","journal-title":"Ann Neurol"},{"issue":"4","key":"3472_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/ana.26452","volume":"92","author":"JP Steiner","year":"2022","unstructured":"Steiner JP, Bachani M, Malik N, DeMarino C, Li W, Sampson K et al (2022) Human endogenous retrovirus K envelope in spinal fluid of amyotrophic lateral sclerosis is toxic. Ann Neurol 92(4):545\u2013561","journal-title":"Ann Neurol"},{"issue":"9","key":"3472_CR23","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106423","volume":"40","author":"ME J\u00f6nsson","year":"2021","unstructured":"J\u00f6nsson ME, Garza R, Sharma Y, Petri R, S\u00f6dersten E, Johansson JG et al (2021) Activation of endogenous retroviruses during brain development causes an inflammatory response. EMBO J 40(9):e106423","journal-title":"EMBO J"},{"issue":"20","key":"3472_CR24","doi-asserted-by":"publisher","first-page":"9338","DOI":"10.1128\/JVI.01503-16","volume":"90","author":"M Manghera","year":"2016","unstructured":"Manghera M, Ferguson-Parry J, Lin R, Douville RN (2016) NF-\u03baB and IRF1 induce endogenous retrovirus K expression via interferon-stimulated response elements in its 5\u2032 long terminal repeat. J Virol 90(20):9338\u20139349","journal-title":"J Virol"},{"issue":"1","key":"3472_CR25","first-page":"1","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W et al (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3(1):1\u201319","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"3472_CR26","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1001\/jamaneurol.2019.2044","volume":"76","author":"M Ryan","year":"2019","unstructured":"Ryan M, Heverin M, McLaughlin RL, Hardiman O (2019) Lifetime risk and heritability of amyotrophic lateral sclerosis. JAMA Neurol 76(11):1367\u20131374","journal-title":"JAMA Neurol"},{"issue":"2","key":"3472_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez M, Mackenzie Ian R, Boeve Bradley F, Boxer Adam L, Baker M, Rutherford Nicola J et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72(2):245\u2013256","journal-title":"Neuron"},{"issue":"2","key":"3472_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton AE, Majounie E, Waite A, Sim\u00f3n-S\u00e1nchez J, Rollinson S, Gibbs JR et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72(2):257\u2013268","journal-title":"Neuron"},{"key":"3472_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A et al (1993) Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59","journal-title":"Nature"},{"issue":"5918","key":"3472_CR30","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.1165942","volume":"323","author":"C Vance","year":"2009","unstructured":"Vance C, Rogelj B, Hortob\u00e1gyi T, De Vos KJ, Nishimura AL, Sreedharan J et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323(5918):1208\u20131211","journal-title":"Science"},{"issue":"5918","key":"3472_CR31","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1126\/science.1166066","volume":"323","author":"TJ Kwiatkowski","year":"2009","unstructured":"Kwiatkowski TJ, Bosco D, Leclerc A, Tamrazian E, Vanderburg C, Russ C et al (2009) Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323(5918):1205\u20131208","journal-title":"Science"},{"issue":"6","key":"3472_CR32","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.tig.2018.03.001","volume":"34","author":"HP Nguyen","year":"2018","unstructured":"Nguyen HP, Van Broeckhoven C, van der Zee J (2018) ALS genes in the genomic era and their implications for FTD. Trends Genet 34(6):404\u2013423","journal-title":"Trends Genet"},{"issue":"11","key":"3472_CR33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.molmed.2011.06.004","volume":"17","author":"TJ Cohen","year":"2011","unstructured":"Cohen TJ, Lee VM, Trojanowski JQ (2011) TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med 17(11):659\u2013667","journal-title":"Trends Mol Med"},{"issue":"4","key":"3472_CR34","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/00005072-199604000-00011","volume":"55","author":"N Shibata","year":"1996","unstructured":"Shibata N, Hirano A, Kobayashi M, Siddique T, Deng H-X, Hung W-Y et al (1996) Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol 55(4):481\u2013490","journal-title":"J Neuropathol Exp Neurol"},{"key":"3472_CR35","doi-asserted-by":"crossref","unstructured":"Spalloni A, Nutini M, Longone P (2019) Glutamate in amyotrophic lateral sclerosis: an ageless contestant. Pathology, prevention and therapeutics of neurodegenerative disease: Springer. p. 61\u201371","DOI":"10.1007\/978-981-13-0944-1_6"},{"key":"3472_CR36","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.brainres.2016.03.032","volume":"1648","author":"C Ruegsegger","year":"2016","unstructured":"Ruegsegger C, Saxena S (2016) Proteostasis impairment in ALS. Brain Res 1648:571\u2013579","journal-title":"Brain Res"},{"key":"3472_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.nbd.2017.04.010","volume":"105","author":"ST Brady","year":"2017","unstructured":"Brady ST, Morfini GA (2017) Regulation of motor proteins, axonal transport deficits and adult-onset neurodegenerative diseases. Neurobiol Dis 105:273\u2013282","journal-title":"Neurobiol Dis"},{"issue":"4","key":"3472_CR38","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/antiox10040552","volume":"10","author":"J Harley","year":"2021","unstructured":"Harley J, Clarke BE, Patani R (2021) The interplay of RNA binding proteins, oxidative stress and mitochondrial dysfunction in ALS. Antioxidants 10(4):552","journal-title":"Antioxidants"},{"key":"3472_CR39","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu J, Wang F (2017) Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications. Front Immunol 8:1005","journal-title":"Front Immunol"},{"issue":"1","key":"3472_CR40","doi-asserted-by":"publisher","first-page":"7083","DOI":"10.1038\/s41598-018-25008-4","volume":"8","author":"ES Pinarbasi","year":"2018","unstructured":"Pinarbasi ES, Ca\u011fatay T, Fung HYJ, Li YC, Chook YM, Thomas PJ (2018) Active nuclear import and passive nuclear export are the primary determinants of TDP-43 localization. Sci Rep 8(1):7083","journal-title":"Sci Rep"},{"issue":"39","key":"3472_CR41","doi-asserted-by":"publisher","first-page":"36337","DOI":"10.1074\/jbc.M104236200","volume":"276","author":"E Buratti","year":"2001","unstructured":"Buratti E, Baralle FE (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator ofCFTR exon 9. J Biol Chem 276(39):36337\u201336343","journal-title":"J Biol Chem"},{"issue":"45","key":"3472_CR42","doi-asserted-by":"publisher","first-page":"37572","DOI":"10.1074\/jbc.M505557200","volume":"280","author":"E Buratti","year":"2005","unstructured":"Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, Baralle FE (2005) TDP-43 binds heterogeneous nuclear ribonucleoprotein a\/b through its c-terminal tail an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem 280(45):37572\u201337584","journal-title":"J Biol Chem"},{"key":"3472_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3121","volume":"13","author":"EB Lee","year":"2011","unstructured":"Lee EB, Lee VMY, Trojanowski JQ (2011) Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci 13:38","journal-title":"Nat Rev Neurosci"},{"key":"3472_CR44","doi-asserted-by":"crossref","unstructured":"Reddi PP ed (2017) Transcription and splicing factor TDP-43: role in regulation of gene expression in testis. Semin Reprod Med; Thieme Medical Publishers","DOI":"10.1055\/s-0037-1599088"},{"issue":"3","key":"3472_CR45","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.neuron.2013.12.018","volume":"81","author":"NH Alami","year":"2014","unstructured":"Alami NH, Smith RB, Carrasco MA, Williams LA, Winborn CS, Han SS et al (2014) Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron 81(3):536\u2013543","journal-title":"Neuron"},{"issue":"4","key":"3472_CR46","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1471-4159.2009.06383.x","volume":"111","author":"C Colombrita","year":"2009","unstructured":"Colombrita C, Zennaro E, Fallini C, Weber M, Sommacal A, Buratti E et al (2009) TDP-43 is recruited to stress granules in conditions of oxidative insult. J Neurochem 111(4):1051\u20131061","journal-title":"J Neurochem"},{"issue":"6","key":"3472_CR47","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1128\/jvi.69.6.3584-3596.1995","volume":"69","author":"SH Ou","year":"1995","unstructured":"Ou SH, Wu F, Harrich D, Garc\u00eda-Mart\u00ednez LF, Gaynor RB (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 69(6):3584","journal-title":"J Virol"},{"issue":"2","key":"3472_CR48","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.ydbio.2006.04.443","volume":"295","author":"KK Acharya","year":"2006","unstructured":"Acharya KK, Govind CK, Shore AN, Stoler MH, Reddi PP (2006) cis-Requirement for the maintenance of round spermatid-specific transcription. Dev Biol 295(2):781\u201390","journal-title":"Dev Biol"},{"issue":"13","key":"3472_CR49","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1074\/jbc.M110.166587","volume":"286","author":"AS Lalmansingh","year":"2011","unstructured":"Lalmansingh AS, Urekar CJ, Reddi PP (2011) TDP-43 is a transcriptional repressor: the testis-specific mouse acrv1 gene is a TDP-43 target in vivo. J Biol Chem 286(13):10970\u201382","journal-title":"J Biol Chem"},{"issue":"7","key":"3472_CR50","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1093\/emboj\/20.7.1774","volume":"20","author":"E Buratti","year":"2001","unstructured":"Buratti E, D\u00f6rk T, Zuccato E, Pagani F, Romano M, Baralle FE (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J 20(7):1774\u20131784","journal-title":"EMBO J"},{"issue":"43","key":"3472_CR51","doi-asserted-by":"publisher","first-page":"28852","DOI":"10.1074\/jbc.M805376200","volume":"283","author":"JK Bose","year":"2008","unstructured":"Bose JK, Wang I-F, Hung L, Tarn W-Y, Shen C-KJ (2008) TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing\u2217. J Biol Chem 283(43):28852\u20139","journal-title":"J Biol Chem"},{"issue":"12","key":"3472_CR52","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1091\/mbc.e09-02-0168","volume":"20","author":"Y Hashimoto","year":"2009","unstructured":"Hashimoto Y, Kurita M, Aiso S, Nishimoto I, Matsuoka M (2009) Humanin inhibits neuronal cell death by interacting with a cytokine receptor complex or complexes involving CNTF receptor alpha\/WSX-1\/gp130. Mol Biol Cell 20(12):2864\u20132873","journal-title":"Mol Biol Cell"},{"issue":"4","key":"3472_CR53","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nn.2778","volume":"14","author":"JR Tollervey","year":"2011","unstructured":"Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M et al (2011) Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci 14(4):452\u2013458","journal-title":"Nat Neurosci"},{"key":"3472_CR54","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nn.2779","volume":"14","author":"M Polymenidou","year":"2011","unstructured":"Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY et al (2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 14:459","journal-title":"Nat Neurosci"},{"issue":"3","key":"3472_CR55","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351(3):602\u2013611","journal-title":"Biochem Biophys Res Commun"},{"issue":"s1","key":"3472_CR56","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.3233\/JAD-2012-129036","volume":"33","author":"TF Gendron","year":"2013","unstructured":"Gendron TF, Rademakers R, Petrucelli L (2013) TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43. J Alzheimers Dis 33(s1):S35\u2013S45","journal-title":"J Alzheimers Dis"},{"issue":"5870","key":"3472_CR57","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.1154584","volume":"319","author":"J Sreedharan","year":"2008","unstructured":"Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B et al (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319(5870):1668\u20131672","journal-title":"Science"},{"issue":"10","key":"3472_CR58","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","volume":"52","author":"M Jo","year":"2020","unstructured":"Jo M, Lee S, Jeon Y-M, Kim S, Kwon Y, Kim H-J (2020) The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies. Exp Mol Med 52(10):1652\u20131662","journal-title":"Exp Mol Med"},{"issue":"7","key":"3472_CR59","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nsmb.2053","volume":"18","author":"W Guo","year":"2011","unstructured":"Guo W, Chen Y, Zhou X, Kar A, Ray P, Chen X et al (2011) An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat Struct Mol Biol 18(7):822","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"3472_CR60","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s13311-015-0338-x","volume":"12","author":"EL Scotter","year":"2015","unstructured":"Scotter EL, Chen H-J, Shaw CE (2015) TDP-43 proteinopathy and ALS: insights into disease mechanisms and therapeutic targets. Neurotherapeutics 12(2):352\u2013363","journal-title":"Neurotherapeutics"},{"issue":"2","key":"3472_CR61","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/emboj.2010.310","volume":"30","author":"YM Ayala","year":"2011","unstructured":"Ayala YM, De Conti L, Avenda\u00f1o-V\u00e1zquez SE, Dhir A, Romano M, D\u2019Ambrogio A et al (2011) TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J 30(2):277\u2013288","journal-title":"EMBO J"},{"issue":"6","key":"3472_CR62","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910622","volume":"12","author":"CC Wu","year":"2020","unstructured":"Wu CC, Jin LW, Wang IF, Wei WY, Ho PC, Liu YC et al (2020) HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP-43 proteinopathies. EMBO Mol Med 12(6):e10622","journal-title":"EMBO Mol Med"},{"issue":"10","key":"3472_CR63","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1073\/pnas.1818415116","volume":"116","author":"J Mitra","year":"2019","unstructured":"Mitra J, Guerrero EN, Hegde PM, Liachko NF, Wang H, Vasquez V et al (2019) Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects. Proc Natl Acad Sci 116(10):4696\u20134705","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"3472_CR64","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.celrep.2019.04.003","volume":"27","author":"EY Liu","year":"2019","unstructured":"Liu EY, Russ J, Cali CP, Phan JM, Amlie-Wolf A, Lee EB (2019) Loss of nuclear TDP-43 is associated with decondensation of LINE retrotransposons. Cell Rep 27(5):1409\u201321.e6","journal-title":"Cell Rep"},{"issue":"6","key":"3472_CR65","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/nan.12148","volume":"40","author":"JR Highley","year":"2014","unstructured":"Highley JR, Kirby J, Jansweijer JA, Webb PS, Hewamadduma CA, Heath PR et al (2014) Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones. Neuropathol Appl Neurobiol 40(6):670\u2013685","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"3472_CR66","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1523\/JNEUROSCI.4988-09.2010","volume":"30","author":"SJ Barmada","year":"2010","unstructured":"Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S (2010) Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci 30(2):639","journal-title":"J Neurosci"},{"key":"3472_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.840357","volume":"16","author":"RT Bjork","year":"2022","unstructured":"Bjork RT, Mortimore NP, Loganathan S, Zarnescu DC (2022) Dysregulation of translation in TDP-43 proteinopathies: deficits in the rna supply chain and local protein production. Front Neurosci 16:840357","journal-title":"Front Neurosci"},{"key":"3472_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2019.103396","volume":"100","author":"J Gao","year":"2019","unstructured":"Gao J, Wang L, Yan T, Perry G, Wang X (2019) TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration. Mol Cell Neurosci 100:103396","journal-title":"Mol Cell Neurosci"},{"issue":"4","key":"3472_CR69","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3109\/21678421.2012.734520","volume":"14","author":"RK Narayanan","year":"2013","unstructured":"Narayanan RK, Mangelsdorf M, Panwar A, Butler TJ, Noakes PG, Wallace RH (2013) Identification of RNA bound to the TDP-43 ribonucleoprotein complex in the adult mouse brain. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14(4):252\u2013260","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"issue":"1","key":"3472_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-27221-8","volume":"12","author":"T Altman","year":"2021","unstructured":"Altman T, Ionescu A, Ibraheem A, Priesmann D, Gradus-Pery T, Farberov L et al (2021) Axonal TDP-43 condensates drive neuromuscular junction disruption through inhibition of local synthesis of nuclear encoded mitochondrial proteins. Nat Commun 12(1):1\u201317","journal-title":"Nat Commun"},{"issue":"32","key":"3472_CR71","doi-asserted-by":"publisher","first-page":"10851","DOI":"10.1523\/JNEUROSCI.1630-10.2010","volume":"30","author":"Y-F Xu","year":"2010","unstructured":"Xu Y-F, Gendron TF, Zhang Y-J, Lin W-L, Alton S, Sheng H et al (2010) Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci 30(32):10851","journal-title":"J Neurosci"},{"issue":"8","key":"3472_CR72","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nm.4130","volume":"22","author":"W Wang","year":"2016","unstructured":"Wang W, Wang L, Lu J, Siedlak SL, Fujioka H, Liang J et al (2016) The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat Med 22(8):869\u2013878","journal-title":"Nat Med"},{"issue":"37","key":"3472_CR73","doi-asserted-by":"publisher","first-page":"19437","DOI":"10.1074\/jbc.M116.737726","volume":"291","author":"R Cascella","year":"2016","unstructured":"Cascella R, Capitini C, Fani G, Dobson CM, Cecchi C, Chiti F (2016) Quantification of the relative contributions of loss-of-function and gain-of-function mechanisms in TAR DNA-binding protein 43 (TDP-43) proteinopathies. J Biol Chem 291(37):19437\u201319448","journal-title":"J Biol Chem"},{"issue":"5","key":"3472_CR74","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/WCO.0000000000000983","volume":"34","author":"SH Appel","year":"2021","unstructured":"Appel SH, Beers DR, Zhao W (2021) Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegeneration. Curr Opin Neurol 34(5):765\u2013772","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"3472_CR75","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/jamaneurol.2018.0035","volume":"75","author":"RK Sheean","year":"2018","unstructured":"Sheean RK, McKay FC, Cretney E, Bye CR, Perera ND, Tomas D et al (2018) Association of regulatory T-cell expansion with progression of amyotrophic lateral sclerosis: a study of humans and a transgenic mouse model. JAMA Neurol 75(6):681\u2013689","journal-title":"JAMA Neurol"},{"issue":"39","key":"3472_CR76","doi-asserted-by":"publisher","first-page":"E8294","DOI":"10.1073\/pnas.1704294114","volume":"114","author":"ND Rudnick","year":"2017","unstructured":"Rudnick ND, Griffey CJ, Guarnieri P, Gerbino V, Wang X, Piersaint JA et al (2017) Distinct roles for motor neuron autophagy early and late in the SOD1G93A mouse model of ALS. Proc Natl Acad Sci 114(39):E8294\u2013E8303","journal-title":"Proc Natl Acad Sci"},{"issue":"347","key":"3472_CR77","doi-asserted-by":"publisher","first-page":"347ra93","DOI":"10.1126\/scitranslmed.aaf6038","volume":"8","author":"A Burberry","year":"2016","unstructured":"Burberry A, Suzuki N, Wang J-Y, Moccia R, Mordes DA, Stewart MH et al (2016) Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci Transl Med 8(347):347ra93-ra93","journal-title":"Sci Transl Med"},{"issue":"1","key":"3472_CR78","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12974-018-1217-2","volume":"15","author":"JD Lee","year":"2018","unstructured":"Lee JD, Levin SC, Willis EF, Li R, Woodruff TM, Noakes PG (2018) Complement components are upregulated and correlate with disease progression in the TDP-43Q331K mouse model of amyotrophic lateral sclerosis. J Neuroinflammation 15(1):171","journal-title":"J Neuroinflammation"},{"issue":"6","key":"3472_CR79","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1073\/pnas.1815961116","volume":"116","author":"E Coque","year":"2019","unstructured":"Coque E, Salsac C, Espinosa-Carrasco G, Varga B, Degauque N, Cadoux M et al (2019) Cytotoxic CD8+ T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneurons. Proc Natl Acad Sci 116(6):2312\u20132317","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"3472_CR80","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.cell.2018.08.035","volume":"174","author":"H Yu","year":"2018","unstructured":"Yu H, Cleveland DW (2018) Tuning apoptosis and neuroinflammation: TBK1 restrains RIPK1. Cell 174(6):1339\u20131341","journal-title":"Cell"},{"issue":"1","key":"3472_CR81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"M Jin","year":"2020","unstructured":"Jin M, G\u00fcnther R, Akg\u00fcn K, Hermann A, Ziemssen T (2020) Peripheral proinflammatory Th1\/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis. Sci Rep 10(1):1\u201313","journal-title":"Sci Rep"},{"issue":"3\u20134","key":"3472_CR82","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000522078","volume":"21","author":"Q Sun","year":"2021","unstructured":"Sun Q, Huo Y, Bai J, Wang H, Wang H, Yang F et al (2021) Inflammatory cytokine levels in patients with sporadic amyotrophic lateral sclerosis. Neurodegener Dis 21(3\u20134):87\u201392","journal-title":"Neurodegener Dis"},{"issue":"7","key":"3472_CR83","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/acn3.51078","volume":"7","author":"F Huang","year":"2020","unstructured":"Huang F, Zhu Y, Hsiao-Nakamoto J, Tang X, Dugas JC, Moscovitch-Lopatin M et al (2020) Longitudinal biomarkers in amyotrophic lateral sclerosis. Ann Clin Transl Neurol 7(7):1103\u20131116","journal-title":"Ann Clin Transl Neurol"},{"issue":"12","key":"3472_CR84","first-page":"1338","volume":"90","author":"B Gille","year":"2019","unstructured":"Gille B, De Schaepdryver M, Dedeene L, Goossens J, Claeys KG, Van Den Bosch L et al (2019) Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry 90(12):1338\u20131346","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"3472_CR85","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/ene.15237","volume":"29","author":"SR Shepheard","year":"2022","unstructured":"Shepheard SR, Karnaros V, Benyamin B, Schultz DW, Dubowsky M, Wuu J et al (2022) Urinary neopterin: a novel biomarker of disease progression in amyotrophic lateral sclerosis. Eur J Neurol 29(4):990\u2013999","journal-title":"Eur J Neurol"},{"issue":"3","key":"3472_CR86","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cell.2020.09.020","volume":"183","author":"C-H Yu","year":"2020","unstructured":"Yu C-H, Davidson S, Harapas CR, Hilton JB, Mlodzianoski MJ, Laohamonthonkul P et al (2020) TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS\/STING in ALS. Cell 183(3):636-649.e18","journal-title":"Cell"},{"key":"3472_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.621501","volume":"15","author":"AL Fryer","year":"2021","unstructured":"Fryer AL, Abdullah A, Taylor JM, Crack PJ (2021) The complexity of the cGAS-STING pathway in CNS pathologies. Front Neurosci 15:621501","journal-title":"Front Neurosci"},{"issue":"6","key":"3472_CR88","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.cytogfr.2014.06.006","volume":"25","author":"C Shu","year":"2014","unstructured":"Shu C, Li X, Li P (2014) The mechanism of double-stranded DNA sensing through the cGAS-STING pathway. Cytokine Growth Factor Rev 25(6):641\u2013648","journal-title":"Cytokine Growth Factor Rev"},{"issue":"9","key":"3472_CR89","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout A, Katz JD, Venkatraman S, Ablasser A (2021) The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol 21(9):548\u2013569","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"3472_CR90","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00702-017-1745-4","volume":"125","author":"JM Taylor","year":"2018","unstructured":"Taylor JM, Moore Z, Minter MR, Crack PJ (2018) Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer\u2019s disease. J Neural Transm 125(5):797\u2013807","journal-title":"J Neural Transm"},{"issue":"3","key":"3472_CR91","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cytogfr.2013.03.006","volume":"24","author":"MJ Hofer","year":"2013","unstructured":"Hofer MJ, Campbell IL (2013) Type I interferon in neurological disease\u2014the devil from within. Cytokine Growth Factor Rev 24(3):257\u2013267","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"3472_CR92","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.tins.2020.10.008","volume":"44","author":"BD Paul","year":"2021","unstructured":"Paul BD, Snyder SH, Bohr VA (2021) Signaling by cGAS\u2013STING in neurodegeneration, neuroinflammation, and aging. Trends Neurosci 44(2):83\u201396","journal-title":"Trends Neurosci"},{"issue":"7823","key":"3472_CR93","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41586-020-2625-x","volume":"585","author":"ME McCauley","year":"2020","unstructured":"McCauley ME, O\u2019Rourke JG, Y\u00e1\u00f1ez A, Markman JL, Ho R, Wang X et al (2020) C9orf72 in myeloid cells suppresses STING-induced inflammation. Nature 585(7823):96\u2013101","journal-title":"Nature"},{"issue":"7","key":"3472_CR94","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/glia.23592","volume":"67","author":"A Nazmi","year":"2019","unstructured":"Nazmi A, Field RH, Griffin EW, Haugh O, Hennessy E, Cox D et al (2019) Chronic neurodegeneration induces type I interferon synthesis via STING, shaping microglial phenotype and accelerating disease progression. Glia 67(7):1254\u20131276","journal-title":"Glia"},{"issue":"7713","key":"3472_CR95","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","volume":"559","author":"SM Haag","year":"2018","unstructured":"Haag SM, Gulen MF, Reymond L, Gibelin A, Abrami L, Decout A et al (2018) Targeting STING with covalent small-molecule inhibitors. Nature 559(7713):269\u2013273","journal-title":"Nature"},{"issue":"6229","key":"3472_CR96","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.aaa3650","volume":"347","author":"ET Cirulli","year":"2015","unstructured":"Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS et al (2015) Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347(6229):1436\u20131441","journal-title":"Science"},{"issue":"5","key":"3472_CR97","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nn.4000","volume":"18","author":"A Freischmidt","year":"2015","unstructured":"Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, M\u00fcller K et al (2015) Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci 18(5):631\u2013636","journal-title":"Nat Neurosci"},{"issue":"6","key":"3472_CR98","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.molmed.2016.04.006","volume":"22","author":"L Ahmad","year":"2016","unstructured":"Ahmad L, Zhang S-Y, Casanova J-L, Sancho-Shimizu V (2016) Human TBK1: a gatekeeper of neuroinflammation. Trends Mol Med 22(6):511\u2013527","journal-title":"Trends Mol Med"},{"issue":"1","key":"3472_CR99","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13041-017-0287-x","volume":"10","author":"JA Oakes","year":"2017","unstructured":"Oakes JA, Davies MC, Collins MO (2017) TBK1: a new player in ALS linking autophagy and neuroinflammation. Mol Brain 10(1):5","journal-title":"Mol Brain"},{"issue":"1","key":"3472_CR100","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1742-2094-11-98","volume":"11","author":"JD Cherry","year":"2014","unstructured":"Cherry JD, Olschowka JA, O\u2019Banion MK (2014) Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 11(1):98","journal-title":"J Neuroinflammation"},{"issue":"2","key":"3472_CR101","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/bpa.12352","volume":"26","author":"F Puentes","year":"2016","unstructured":"Puentes F, Malaspina A, van Noort JM, Amor S (2016) Non-neuronal cells in ALS: role of glial, immune cells and blood-CNS barriers. Brain Pathol 26(2):248\u2013257","journal-title":"Brain Pathol"},{"key":"3472_CR102","doi-asserted-by":"crossref","unstructured":"Geloso MC, Corvino V, Marchese E, Serrano A, Michetti F, D\u2019Ambrosi N (2017) The dual role of microglia in ALS: mechanisms and therapeutic approaches. Front Aging Neurosci 9(242)","DOI":"10.3389\/fnagi.2017.00242"},{"issue":"12","key":"3472_CR103","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1093\/brain\/awaa309","volume":"143","author":"BE Clarke","year":"2020","unstructured":"Clarke BE, Patani R (2020) The microglial component of amyotrophic lateral sclerosis. Brain 143(12):3526\u20133539","journal-title":"Brain"},{"key":"3472_CR104","doi-asserted-by":"crossref","unstructured":"Tortarolo M, Lo Coco D, Veglianese P, Vallarola A, Giordana MT, Marcon G, et al (2017) Amyotrophic lateral sclerosis, a multisystem pathology: insights into the role of TNF\u03b1. Mediators Inflamm 2017","DOI":"10.1155\/2017\/2985051"},{"issue":"1","key":"3472_CR105","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0022-510X(01)00514-7","volume":"187","author":"S Ono","year":"2001","unstructured":"Ono S, Hu J, Shimizu N, Imai T, Nakagawa H (2001) Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis. J Neurol Sci 187(1):27\u201334","journal-title":"J Neurol Sci"},{"issue":"2","key":"3472_CR106","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3390\/ijms19020423","volume":"19","author":"S Garbuzova-Davis","year":"2018","unstructured":"Garbuzova-Davis S, Ehrhart J, Sanberg PR, Borlongan CV (2018) Potential role of humoral IL-6 cytokine in mediating pro-inflammatory endothelial cell response in amyotrophic lateral sclerosis. Int J Mol Sci 19(2):423","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3472_CR107","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.neuron.2014.01.013","volume":"81","author":"AE Frakes","year":"2014","unstructured":"Frakes AE, Ferraiuolo L, Haidet-Phillips AM, Schmelzer L, Braun L, Miranda CJ et al (2014) Microglia induce motor neuron death via the classical NF-\u03baB pathway in amyotrophic lateral sclerosis. Neuron 81(5):1009\u20131023","journal-title":"Neuron"},{"key":"3472_CR108","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.expneurol.2015.07.019","volume":"273","author":"W Zhao","year":"2015","unstructured":"Zhao W, Beers DR, Bell S, Wang J, Wen S, Baloh RH et al (2015) TDP-43 activates microglia through NF-\u03baB and NLRP3 inflammasome. Exp Neurol 273:24\u201335","journal-title":"Exp Neurol"},{"issue":"1","key":"3472_CR109","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s40478-021-01239-x","volume":"9","author":"M Hunter","year":"2021","unstructured":"Hunter M, Spiller KJ, Dominique MA, Xu H, Hunter FW, Fang TC et al (2021) Microglial transcriptome analysis in the rNLS8 mouse model of TDP-43 proteinopathy reveals discrete expression profiles associated with neurodegenerative progression and recovery. Acta Neuropathol Commun 9(1):140","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"3472_CR110","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nn1876","volume":"10","author":"M Nagai","year":"2007","unstructured":"Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H et al (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10(5):615\u2013622","journal-title":"Nat Neurosci"},{"issue":"13","key":"3472_CR111","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1038\/emboj.2013.122","volume":"32","author":"J Tong","year":"2013","unstructured":"Tong J, Huang C, Bi F, Wu Q, Huang B, Liu X et al (2013) Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO J 32(13):1917\u20131926","journal-title":"EMBO J"},{"key":"3472_CR112","doi-asserted-by":"crossref","unstructured":"Vaz SH, Pinto S, Sebasti\u00e3o AM, Brites D (2021) Astrocytes in amyotrophic lateral sclerosis. Exon Publications:35\u201353","DOI":"10.36255\/exonpublications.amyotrophiclateralsclerosis.astrocytes.2021"},{"issue":"1","key":"3472_CR113","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00441-020-03253-2","volume":"382","author":"T Brigadski","year":"2020","unstructured":"Brigadski T, Le\u00dfmann V (2020) The physiology of regulated BDNF release. Cell Tissue Res 382(1):15\u201345","journal-title":"Cell Tissue Res"},{"issue":"2","key":"3472_CR114","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/cen3.12309","volume":"7","author":"F Endo","year":"2016","unstructured":"Endo F, Komine O, Yamanaka K (2016) Neuroinflammation in motor neuron disease. Clin Exp Neuroimmunol 7(2):126\u2013138","journal-title":"Clin Exp Neuroimmunol"},{"issue":"2","key":"3472_CR115","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.stemcr.2017.06.008","volume":"9","author":"P Tripathi","year":"2017","unstructured":"Tripathi P, Rodriguez-Muela N, Klim JR, de Boer AS, Agrawal S, Sandoe J et al (2017) Reactive astrocytes promote ALS-like degeneration and intracellular protein aggregation in human motor neurons by disrupting autophagy through TGF-\u03b21. Stem Cell Rep 9(2):667\u2013680","journal-title":"Stem Cell Rep"},{"issue":"4","key":"3472_CR116","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.celrep.2015.03.053","volume":"11","author":"F Endo","year":"2015","unstructured":"Endo F, Komine O, Fujimori-Tonou N, Katsuno M, Jin S, Watanabe S et al (2015) Astrocyte-derived TGF-\u03b21 accelerates disease progression in ALS mice by interfering with the neuroprotective functions of microglia and T cells. Cell Rep 11(4):592\u2013604","journal-title":"Cell Rep"},{"issue":"1","key":"3472_CR117","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12974-016-0698-0","volume":"13","author":"P-S Mishra","year":"2016","unstructured":"Mishra P-S, Dhull DK, Nalini A, Vijayalakshmi K, Sathyaprabha TN, Alladi PA et al (2016) Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients. J Neuroinflammation 13(1):212","journal-title":"J Neuroinflammation"},{"issue":"3","key":"3472_CR118","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/intimm\/dxu099","volume":"27","author":"A Malaspina","year":"2015","unstructured":"Malaspina A, Puentes F, Amor S (2015) Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective. Int Immunol 27(3):117\u2013129","journal-title":"Int Immunol"},{"key":"3472_CR119","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fimmu.2015.00539","volume":"6","author":"PA Ottum","year":"2015","unstructured":"Ottum PA, Arellano G, Reyes LI, Iruretagoyena M, Naves R (2015) Opposing roles of interferon-gamma on cells of the central nervous system in autoimmune neuroinflammation. Front Immunol 6:539","journal-title":"Front Immunol"},{"issue":"1","key":"3472_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5607\/en.2015.24.1.1","volume":"24","author":"S Lee","year":"2015","unstructured":"Lee S, Kim H-J (2015) Prion-like mechanism in amyotrophic lateral sclerosis: are protein aggregates the key? Exp Neurobiol 24(1):1\u20137","journal-title":"Exp Neurobiol"},{"issue":"3","key":"3472_CR121","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.cell.2011.10.011","volume":"147","author":"M Polymenidou","year":"2011","unstructured":"Polymenidou M, Cleveland DW (2011) The seeds of neurodegeneration: prion-like spreading in ALS. Cell 147(3):498\u2013508","journal-title":"Cell"},{"issue":"3","key":"3472_CR122","first-page":"305","volume":"1","author":"MT Mizwicki","year":"2012","unstructured":"Mizwicki MT, Fiala M, Magpantay L, Aziz N, Sayre J, Liu G et al (2012) Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling. Am J Neurodegener Dis 1(3):305","journal-title":"Am J Neurodegener Dis"},{"issue":"9","key":"3472_CR123","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1523\/JNEUROSCI.5253-05.2006","volume":"26","author":"M Kiaei","year":"2006","unstructured":"Kiaei M, Petri S, Kipiani K, Gardian G, Choi D-K, Chen J et al (2006) Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci 26(9):2467\u20132473","journal-title":"J Neurosci"},{"issue":"5\u20136","key":"3472_CR124","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3109\/17482960802709416","volume":"10","author":"EW Stommel","year":"2009","unstructured":"Stommel EW, Cohen JA, Fadul CE, Cogbill CH, Graber DJ, Kingman L et al (2009) Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trial. Amyotroph Lateral Scler 10(5\u20136):393\u2013404","journal-title":"Amyotroph Lateral Scler"},{"issue":"3","key":"3472_CR125","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000100","volume":"2","author":"RG Miller","year":"2015","unstructured":"Miller RG, Block G, Katz JS, Barohn RJ, Gopalakrishnan V, Cudkowicz M et al (2015) Randomized phase 2 trial of NP001-a novel immune regulator: safety and early efficacy in ALS. Neurol Neuroimmunol Neuroinflamm 2(3):e100","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"3472_CR126","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.tins.2020.12.001","volume":"44","author":"JD Lee","year":"2021","unstructured":"Lee JD, Woodruff TM (2021) TDP-43 Puts the STING in ALS. Trends Neurosci 44(2):81\u201382","journal-title":"Trends Neurosci"},{"issue":"1","key":"3472_CR127","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.drudis.2019.11.007","volume":"25","author":"X Feng","year":"2020","unstructured":"Feng X, Liu D, Li Z, Bian J (2020) Bioactive modulators targeting STING adaptor in cGAS-STING pathway. Drug Discovery Today 25(1):230\u2013237","journal-title":"Drug Discovery Today"},{"key":"3472_CR128","doi-asserted-by":"crossref","unstructured":"Saxena SK (2016) Advances in molecular retrovirology: BoD\u2013Books on demand","DOI":"10.5772\/60583"},{"key":"3472_CR129","doi-asserted-by":"crossref","unstructured":"Coffin JM (2018) Replication of retrovirus genomes. RNA Genetics: Volume II: Retroviruses, viroids, and RNA recombination","DOI":"10.1201\/9781351076432-1"},{"key":"3472_CR130","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.idcr.2016.03.002","volume":"4","author":"C Isache","year":"2016","unstructured":"Isache C, Sands M, Guzman N, Figueroa D (2016) HTLV-1 and HIV-1 co-infection: a case report and review of the literature. IDCases 4:53\u201355","journal-title":"IDCases"},{"issue":"1","key":"3472_CR131","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12977-018-0442-1","volume":"15","author":"RJ Gifford","year":"2018","unstructured":"Gifford RJ, Blomberg J, Coffin JM, Fan H, Heidmann T, Mayer J et al (2018) Nomenclature for endogenous retrovirus (ERV) loci. Retrovirology 15(1):59","journal-title":"Retrovirology"},{"issue":"1","key":"3472_CR132","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13059-018-1577-z","volume":"19","author":"G Bourque","year":"2018","unstructured":"Bourque G, Burns KH, Gehring M, Gorbunova V, Seluanov A, Hammell M et al (2018) Ten things you should know about transposable elements. Genome Biol 19(1):199","journal-title":"Genome Biol"},{"issue":"17","key":"3472_CR133","doi-asserted-by":"publisher","first-page":"10112","DOI":"10.3390\/ijms231710112","volume":"23","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Pan J, Cong Y, Mao J (2022) Transcriptional regulation of endogenous retroviruses and their misregulation in human diseases. Int J Mol Sci 23(17):10112","journal-title":"Int J Mol Sci"},{"issue":"307","key":"3472_CR134","doi-asserted-by":"publisher","first-page":"307ra153","DOI":"10.1126\/scitranslmed.aac8201","volume":"7","author":"W Li","year":"2015","unstructured":"Li W, Lee M-H, Henderson L, Tyagi R, Bachani M, Steiner J et al (2015) Human endogenous retrovirus-K contributes to motor neuron disease. Sci Transl Med 7(307):307ra153-307ra153","journal-title":"Sci Transl Med"},{"key":"3472_CR135","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.12704","volume":"5","author":"WE Diehl","year":"2016","unstructured":"Diehl WE, Patel N, Halm K, Johnson WE (2016) Tracking interspecies transmission and long-term evolution of an ancient retrovirus using the genomes of modern mammals. Elife 5:e12704","journal-title":"Elife"},{"issue":"4","key":"3472_CR136","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.molmed.2018.02.007","volume":"24","author":"P K\u00fcry","year":"2018","unstructured":"K\u00fcry P, Nath A, Cr\u00e9ange A, Dolei A, Marche P, Gold J et al (2018) Human endogenous retroviruses in neurological diseases. Trends Mol Med 24(4):379\u2013394","journal-title":"Trends Mol Med"},{"key":"3472_CR137","doi-asserted-by":"crossref","unstructured":"Nishat S, Jessica F, Owen H, Seddon J, Simmons G, Speight N, et al (2020) Koala retrovirus viral load and disease burden in distinct northern and southern koala populations. Scientific Reports (Nature Publisher Group). 10(1)","DOI":"10.1038\/s41598-019-56546-0"},{"key":"3472_CR138","unstructured":"Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al (2001) Initial sequencing and analysis of the human genome"},{"issue":"21","key":"3472_CR139","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1007\/s00018-008-8497-0","volume":"65","author":"C Stocking","year":"2008","unstructured":"Stocking C, Kozak C (2008) Endogenous retroviruses. Cell Mol Life Sci 65(21):3383\u20133398","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"3472_CR140","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1101\/gr.130740.111","volume":"22","author":"J Li","year":"2012","unstructured":"Li J, Akagi K, Hu Y, Trivett AL, Hlynialuk CJ, Swing DA et al (2012) Mouse endogenous retroviruses can trigger premature transcriptional termination at a distance. Genome Res 22(5):870\u2013884","journal-title":"Genome Res"},{"issue":"16","key":"3472_CR141","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1073\/pnas.1603569113","volume":"113","author":"J Lenz","year":"2016","unstructured":"Lenz J (2016) HERV-K HML-2 diversity among humans. Proc Natl Acad Sci 113(16):4240","journal-title":"Proc Natl Acad Sci"},{"issue":"19","key":"3472_CR142","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1007\/s00018-015-1947-6","volume":"72","author":"M Suntsova","year":"2015","unstructured":"Suntsova M, Garazha A, Ivanova A, Kaminsky D, Zhavoronkov A, Buzdin A (2015) Molecular functions of human endogenous retroviruses in health and disease. Cell Mol Life Sci 72(19):3653\u20133675","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"3472_CR143","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12026-015-8671-z","volume":"64","author":"BA Nex\u00f8","year":"2016","unstructured":"Nex\u00f8 BA, Villesen P, Nissen KK, Lindegaard HM, Rossing P, Petersen T et al (2016) Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci. Immunol Res 64(1):55\u201363","journal-title":"Immunol Res"},{"key":"3472_CR144","doi-asserted-by":"crossref","unstructured":"Douville RN, Nath A (2014) Chapter 22 - Human endogenous retroviruses and the nervous system. In: Tselis AC, Booss J (eds) Handbook of clinical neurology. 123: Elsevier; p. 465\u201385","DOI":"10.1016\/B978-0-444-53488-0.00022-5"},{"issue":"6771","key":"3472_CR145","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/35001608","volume":"403","author":"S Mi","year":"2000","unstructured":"Mi S, Lee X, Li X-p, Veldman GM, Finnerty H, Racie L et al (2000) Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature. 403(6771):785\u20139","journal-title":"Nature."},{"issue":"10","key":"3472_CR146","doi-asserted-by":"publisher","first-page":"e3000028-e","DOI":"10.1371\/journal.pbio.3000028","volume":"16","author":"EB Chuong","year":"2018","unstructured":"Chuong EB (2018) The placenta goes viral: retroviruses control gene expression in pregnancy. PLoS Biol 16(10):e3000028-e","journal-title":"PLoS Biol"},{"key":"3472_CR147","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cca.2017.09.012","volume":"474","author":"S Qiao","year":"2017","unstructured":"Qiao S, Wang F, Chen H, Jiang S-W (2017) Inducible knockout of syncytin-A gene leads to an extensive placental vasculature deficiency, implications for preeclampsia. Clin Chim Acta 474:137\u2013146","journal-title":"Clin Chim Acta"},{"issue":"1","key":"3472_CR148","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1352458517737370","volume":"24","author":"A Dolei","year":"2018","unstructured":"Dolei A (2018) The aliens inside us: HERV-W endogenous retroviruses and multiple sclerosis. Mult Scler J 24(1):42\u201347","journal-title":"Mult Scler J"},{"key":"3472_CR149","unstructured":"Kremer D, Gruchot J, Weyers V, Oldemeier L, Goettle P, Healy L, et al (eds) (2018) Microglial-dependent neurodegeneration in multiple sclerosis is fueled by HERV-W envelope protein. MULTIPLE SCLEROSIS JOURNAL; SAGE PUBLICATIONS LTD 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND"},{"key":"3472_CR150","doi-asserted-by":"crossref","unstructured":"Ruprecht K, Mayer J (2019) On the origin of a pathogenic HERV-W envelope protein present in multiple sclerosis lesions. Proc Natl Acad Sci U.S.A. 201911703","DOI":"10.1073\/pnas.1911703116"},{"issue":"2","key":"3472_CR151","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/135245859500100205","volume":"1","author":"HB Rasmussen","year":"1995","unstructured":"Rasmussen HB, Geny C, Deforges L, Perron H, Tourtelotte W, Heltberg A et al (1995) Expression of endogenous retroviruses in blood mononuclear cells and brain tissue from multiple sclerosis patients. Mult Scler J 1(2):82\u201387","journal-title":"Mult Scler J"},{"issue":"12","key":"3472_CR152","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1177\/1352458512441381","volume":"18","author":"H Perron","year":"2012","unstructured":"Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, Farinelli L et al (2012) Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult Scler J 18(12):1721\u20131736","journal-title":"Mult Scler J"},{"issue":"2","key":"3472_CR153","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/biomedicines10020387","volume":"10","author":"S P\u00e9rez-P\u00e9rez","year":"2022","unstructured":"P\u00e9rez-P\u00e9rez S, Dom\u00ednguez-Mozo MI, Garc\u00eda-Mart\u00ednez M\u00c1, Ballester-Gonz\u00e1lez R, Nieto-Ga\u00f1\u00e1n I, Arroyo R et al (2022) Epstein-Barr virus load correlates with multiple sclerosis-associated retrovirus envelope expression. Biomedicines 10(2):387","journal-title":"Biomedicines"},{"issue":"1","key":"3472_CR154","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","volume":"21","author":"SS Soldan","year":"2023","unstructured":"Soldan SS, Lieberman PM (2023) Epstein-Barr virus and multiple sclerosis. Nat Rev Microbiol 21(1):51\u201364","journal-title":"Nat Rev Microbiol"},{"key":"3472_CR155","doi-asserted-by":"crossref","unstructured":"Grandi N, Tramontano E (2018) HERV envelope proteins: physiological role and pathogenic potential in cancer and autoimmunity. Front Microbiol 9(462)","DOI":"10.3389\/fmicb.2018.00462"},{"issue":"3","key":"3472_CR156","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s11481-010-9214-y","volume":"5","author":"T Christensen","year":"2010","unstructured":"Christensen T (2010) HERVs in neuropathogenesis. J Neuroimmune Pharmacol 5(3):326\u2013335","journal-title":"J Neuroimmune Pharmacol"},{"issue":"2","key":"3472_CR157","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1158\/1078-0432.CCR-14-0388","volume":"21","author":"K Rycaj","year":"2015","unstructured":"Rycaj K, Plummer JB, Yin B, Li M, Garza J, Radvanyi L et al (2015) Cytotoxicity of human endogenous retrovirus K\u2013specific T cells toward autologous ovarian cancer cells. Clin Cancer Res 21(2):471\u2013483","journal-title":"Clin Cancer Res"},{"issue":"10","key":"3472_CR158","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/sj.onc.1206241","volume":"22","author":"F Wang-Johanning","year":"2003","unstructured":"Wang-Johanning F, Frost AR, Jian B, Epp L, Lu DW, Johanning GL (2003) Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene 22(10):1528\u20131535","journal-title":"Oncogene"},{"issue":"1","key":"3472_CR159","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/cei.12964","volume":"189","author":"G Mameli","year":"2017","unstructured":"Mameli G, Erre GL, Caggiu E, Mura S, Cossu D, Bo M et al (2017) Identification of a HERV-K env surface peptide highly recognized in Rheumatoid Arthritis (RA) patients: a cross-sectional case\u2013control study. Clin Exp Immunol 189(1):127\u2013131","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"3472_CR160","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3109\/15622975.2010.601760","volume":"14","author":"M Leboyer","year":"2013","unstructured":"Leboyer M, Tamouza R, Charron D, Faucard R, Perron H (2013) Human endogenous retrovirus type W (HERV-W) in schizophrenia: a new avenue of research at the gene\u2013environment interface. World J Biol Psychiatry 14(2):80\u201390","journal-title":"World J Biol Psychiatry"},{"key":"3472_CR161","first-page":"183","volume":"6","author":"G Slokar","year":"2016","unstructured":"Slokar G, Hasler G (2016) Human endogenous retroviruses as pathogenic factors in the development of schizophrenia. Front Psych 6:183","journal-title":"Front Psych"},{"key":"3472_CR162","unstructured":"Zimmer K (2019) Human endogenous retroviruses and disease"},{"issue":"1","key":"3472_CR163","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1742-4690-8-90","volume":"8","author":"RP Subramanian","year":"2011","unstructured":"Subramanian RP, Wildschutte JH, Russo C, Coffin JM (2011) Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology 8(1):90","journal-title":"Retrovirology"},{"key":"3472_CR164","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fonc.2013.00246","volume":"3","author":"O Hohn","year":"2013","unstructured":"Hohn O, Hanke K, Bannert N (2013) HERV-K(HML-2), the best preserved family of HERVs: endogenization, expression, and implications in health and disease. Front Oncol 3:246","journal-title":"Front Oncol"},{"key":"3472_CR165","doi-asserted-by":"crossref","unstructured":"Hughes SH (2015) Reverse transcription of retroviruses and LTR retrotransposons. Mobile DNA III: American Society of Microbiology; p. 1051-77","DOI":"10.1128\/9781555819217.ch46"},{"key":"3472_CR166","doi-asserted-by":"crossref","unstructured":"Gifford R, Tristem M (2003) The evolution, distribution and diversity of endogenous retroviruses. 291\u2013315 p","DOI":"10.1023\/A:1024455415443"},{"issue":"2","key":"3472_CR167","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212970","volume":"14","author":"SM Chan","year":"2019","unstructured":"Chan SM, Sapir T, Park S-S, Rual J-F, Contreras-Galindo R, Reiner O et al (2019) The HERV-K accessory protein Np9 controls viability and migration of teratocarcinoma cells. PLoS One 14(2):e0212970","journal-title":"PLoS One"},{"issue":"1","key":"3472_CR168","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13100-015-0035-7","volume":"6","author":"K Schmitt","year":"2015","unstructured":"Schmitt K, Heyne K, Roemer K, Meese E, Mayer J (2015) HERV-K(HML-2) rec and np9 transcripts not restricted to disease but present in many normal human tissues. Mob DNA 6(1):4","journal-title":"Mob DNA"},{"issue":"24","key":"3472_CR169","doi-asserted-by":"publisher","first-page":"15573","DOI":"10.1128\/JVI.79.24.15573-15577.2005","volume":"79","author":"M Dewannieux","year":"2005","unstructured":"Dewannieux M, Blaise S, Heidmann T (2005) Identification of a functional envelope protein from the HERV-K family of human endogenous retroviruses. J Virol 79(24):15573\u201315577","journal-title":"J Virol"},{"issue":"2","key":"3472_CR170","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1099\/vir.0.83534-0","volume":"89","author":"K Boller","year":"2008","unstructured":"Boller K, Sch\u00f6nfeld K, Lischer S, Fischer N, Hoffmann A, Kurth R et al (2008) Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles. J Gen Virol 89(2):567\u2013572","journal-title":"J Gen Virol"},{"issue":"4","key":"3472_CR171","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060605","volume":"8","author":"W Shin","year":"2013","unstructured":"Shin W, Lee J, Son S-Y, Ahn K, Kim H-S, Han K (2013) Human-specific HERV-K insertion causes genomic variations in the human genome. PLoS One 8(4):e60605","journal-title":"PLoS One"},{"issue":"19","key":"3472_CR172","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0960-9822(01)00455-9","volume":"11","author":"G Turner","year":"2001","unstructured":"Turner G, Barbulescu M, Su M, Jensen-Seaman MI, Kidd KK, Lenz J (2001) Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr Biol 11(19):1531\u20131535","journal-title":"Curr Biol"},{"issue":"16","key":"3472_CR173","doi-asserted-by":"publisher","first-page":"E2326","DOI":"10.1073\/pnas.1602336113","volume":"113","author":"JH Wildschutte","year":"2016","unstructured":"Wildschutte JH, Williams ZH, Montesion M, Subramanian RP, Kidd JM, Coffin JM (2016) Discovery of unfixed endogenous retrovirus insertions in diverse human populations. Proc Natl Acad Sci 113(16):E2326\u2013E2334","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"3472_CR174","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1084\/jem.142.2.483","volume":"142","author":"MV Viola","year":"1975","unstructured":"Viola MV, Frazier M, White L, Brody J, Spiegelman S (1975) RNA-instructed DNA polymerase activity in a cytoplasmic particulate fraction in brains from Guamanian patients. J Exp Med 142(2):483\u2013494","journal-title":"J Exp Med"},{"issue":"4","key":"3472_CR175","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/1096-9071(200008)61:4<527::AID-JMV17>3.0.CO;2-A","volume":"61","author":"W Andrews","year":"2000","unstructured":"Andrews W, Tuke P, Al-Chalabi A, Gaudin P, Ijaz S, Parton M et al (2000) Detection of reverse transcriptase activity in the serum of patients with motor neurone disease. J Med Virol 61(4):527\u2013532","journal-title":"J Med Virol"},{"issue":"3","key":"3472_CR176","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1212\/01.WNL.0000150899.76130.71","volume":"64","author":"A Steele","year":"2005","unstructured":"Steele A, Al-Chalabi A, Ferrante K, Cudkowicz M, Brown R, Garson J (2005) Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives. Neurology 64(3):454\u2013458","journal-title":"Neurology"},{"issue":"4","key":"3472_CR177","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/01.wnl.0000297552.13219.b4","volume":"70","author":"A McCormick","year":"2008","unstructured":"McCormick A, Brown R, Cudkowicz M, Al-Chalabi A, Garson J (2008) Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology 70(4):278\u2013283","journal-title":"Neurology"},{"issue":"2","key":"3472_CR178","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.antiviral.2013.05.006","volume":"99","author":"T Alfahad","year":"2013","unstructured":"Alfahad T, Nath A (2013) Retroviruses and amyotrophic lateral sclerosis. Antiviral Res 99(2):180\u2013187","journal-title":"Antiviral Res"},{"issue":"6","key":"3472_CR179","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1212\/WNL.57.6.995","volume":"57","author":"A Moulignier","year":"2001","unstructured":"Moulignier A, Moulonguet A, Pialoux G, Rozenbaum W (2001) Reversible ALS-like disorder in HIV infection. Neurology 57(6):995\u20131001","journal-title":"Neurology"},{"issue":"17","key":"3472_CR180","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1212\/WNL.0000000000003258","volume":"87","author":"LN Bowen","year":"2016","unstructured":"Bowen LN, Tyagi R, Li W, Alfahad T, Smith B, Wright M et al (2016) HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy. Neurology 87(17):1756\u20131762","journal-title":"Neurology"},{"key":"3472_CR181","unstructured":"Hadlock K, Miller R, Jin X, Yu S, Reis J, Mass J, et al (eds) (2004) Elevated rates of antibody reactivity to HML-2\/HERV-K but not other endogenous retroviruses in ALS. Neurology; LIPPINCOTT WILLIAMS & WILKINS 530 WALNUT ST, PHILADELPHIA, PA 19106\u20133621 USA"},{"issue":"5","key":"3472_CR182","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/ana.26466","volume":"92","author":"M Garcia-Montojo","year":"2022","unstructured":"Garcia-Montojo M, Simula ER, Fathi S, McMahan C, Ghosal A, Berry JD et al (2022) Antibody response to HML-2 may be protective in amyotrophic lateral sclerosis. Ann Neurol 92(5):782\u2013792","journal-title":"Ann Neurol"},{"key":"3472_CR183","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.nbd.2016.06.017","volume":"94","author":"M Manghera","year":"2016","unstructured":"Manghera M, Ferguson-Parry J, Douville RN (2016) TDP-43 regulates endogenous retrovirus-K viral protein accumulation. Neurobiol Dis 94:226\u2013236","journal-title":"Neurobiol Dis"},{"key":"3472_CR184","doi-asserted-by":"crossref","unstructured":"Chang Y-H, Dubnau J (2022) Endogenous retroviruses and TDP-43 proteinopathy form a sustaining feedback to drive the intercellular spread of neurodegeneration. bioRxiv. 2022.07. 20.500816","DOI":"10.1101\/2022.07.20.500816"},{"issue":"8","key":"3472_CR185","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3390\/v10080412","volume":"10","author":"G Ibba","year":"2018","unstructured":"Ibba G, Piu C, Uleri E, Serra C, Dolei A (2018) Disruption by SaCas9 endonuclease of HERV-Kenv, a retroviral gene with oncogenic and neuropathogenic potential, inhibits molecules involved in cancer and amyotrophic lateral sclerosis. Viruses 10(8):412","journal-title":"Viruses"},{"issue":"15","key":"3472_CR186","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.3390\/ijms20153706","volume":"20","author":"A Dolei","year":"2019","unstructured":"Dolei A, Ibba G, Piu C, Serra C (2019) Expression of HERV genes as possible biomarker and target in neurodegenerative diseases. Int J Mol Sci 20(15):3706","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3472_CR187","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41467-023-36649-z","volume":"14","author":"Y-H Chang","year":"2023","unstructured":"Chang Y-H, Dubnau J (2023) Endogenous retroviruses and TDP-43 proteinopathy form a sustaining feedback driving intercellular spread of drosophila neurodegeneration. Nat Commun 14(1):966","journal-title":"Nat Commun"},{"key":"3472_CR188","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor JP, Brown RH Jr, Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature 539:197","journal-title":"Nature"},{"issue":"1","key":"3472_CR189","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4690-10-16","volume":"10","author":"M Manghera","year":"2013","unstructured":"Manghera M, Douville RN (2013) Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors? Retrovirology 10(1):1\u201311","journal-title":"Retrovirology"},{"issue":"1","key":"3472_CR190","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/v7010320","volume":"7","author":"M Manghera","year":"2015","unstructured":"Manghera M, Ferguson J, Douville R (2015) ERVK polyprotein processing and reverse transcriptase expression in human cell line models of neurological disease. Viruses 7(1):320\u2013332","journal-title":"Viruses"},{"issue":"7","key":"3472_CR191","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.3390\/cells9071584","volume":"9","author":"D Di Curzio","year":"2020","unstructured":"Di Curzio D, Gurm M, Turnbull M, Nadeau M-J, Meek B, Rempel JD et al (2020) Pro-inflammatory signaling upregulates a neurotoxic conotoxin-like protein encrypted within human endogenous retrovirus-K. Cells 9(7):1584","journal-title":"Cells"},{"issue":"8","key":"3472_CR192","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3390\/microorganisms9081784","volume":"9","author":"G Arru","year":"2021","unstructured":"Arru G, Galleri G, Deiana GA, Zarbo IR, Sechi E, Bo M et al (2021) HERV-K modulates the immune response in ALS patients. Microorganisms 9(8):1784","journal-title":"Microorganisms"},{"issue":"19","key":"3472_CR193","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1016\/j.cub.2019.07.071","volume":"29","author":"Y-H Chang","year":"2019","unstructured":"Chang Y-H, Dubnau J (2019) The gypsy endogenous retrovirus drives non-cell-autonomous propagation in a drosophila TDP-43 model of neurodegeneration. Curr Biol 29(19):3135\u201352.e4","journal-title":"Curr Biol"},{"issue":"307","key":"3472_CR194","doi-asserted-by":"publisher","first-page":"307fs40","DOI":"10.1126\/scitranslmed.aad3533","volume":"7","author":"RH Brown","year":"2015","unstructured":"Brown RH, Al-Chalabi A (2015) Endogenous retroviruses in ALS: a reawakening? Sci Transl Med 7(307):307fs40-fs40","journal-title":"Sci Transl Med"},{"issue":"1","key":"3472_CR195","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12977-017-0347-4","volume":"14","author":"R Tyagi","year":"2017","unstructured":"Tyagi R, Li W, Parades D, Bianchet MA, Nath A (2017) Inhibition of human endogenous retrovirus-K by antiretroviral drugs. Retrovirology 14(1):21","journal-title":"Retrovirology"},{"issue":"7","key":"3472_CR196","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1212\/01.WNL.0000156913.24701.72","volume":"64","author":"S Scelsa","year":"2005","unstructured":"Scelsa S, MacGowan D, Mitsumoto H, Imperato T, LeValley A, Liu M et al (2005) A pilot, double-blind, placebo-controlled trial of indinavir in patients with ALS. Neurology 64(7):1298\u20131300","journal-title":"Neurology"},{"issue":"6","key":"3472_CR197","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/00001756-199306000-00056","volume":"4","author":"ME Westarp","year":"1993","unstructured":"Westarp ME, Bartmann P, R\u00f6ssler J, Geiger E, Westphal KP, Schreiber H et al (1993) Antiretroviral therapy in sporadic adult amyotrophic lateral sclerosis. NeuroReport 4(6):819\u2013822","journal-title":"NeuroReport"},{"key":"3472_CR198","doi-asserted-by":"crossref","unstructured":"Gubernick SI, F\u00e9lix N, Lee D, Xu JJ, Hamad B (2016) The HIV therapy market. Nature Publishing Group","DOI":"10.1038\/nrd.2016.69"},{"issue":"4","key":"3472_CR199","first-page":"432","volume":"4","author":"L Ene","year":"2011","unstructured":"Ene L, Duiculescu D, Ruta S (2011) How much do antiretroviral drugs penetrate into the central nervous system? J Med Life 4(4):432","journal-title":"J Med Life"},{"issue":"7","key":"3472_CR200","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/cid\/ciu477","volume":"59","author":"SL Letendre","year":"2014","unstructured":"Letendre SL, Mills AM, Tashima KT, Thomas DA, Min SS, Chen S et al (2014) ING116070: a study of the pharmacokinetics and antiviral activity of Dolutegravir in cerebrospinal fluid in HIV-1\u2013infected, antiretroviral therapy\u2013naive subjects. Clin Infect Dis 59(7):1032\u20131037","journal-title":"Clin Infect Dis"},{"key":"3472_CR201","doi-asserted-by":"crossref","unstructured":"Liu X, Liu Z, Wu Z, Ren J, Fan Y, Sun L, et al (2023) Resurrection of endogenous retroviruses during aging reinforces senescence. Cell","DOI":"10.1016\/j.cell.2022.12.017"},{"issue":"3","key":"3472_CR202","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11904-017-0356-x","volume":"14","author":"CO Hileman","year":"2017","unstructured":"Hileman CO, Funderburg NT (2017) Inflammation, immune activation, and antiretroviral therapy in HIV. Curr HIV\/AIDS Rep 14(3):93\u2013100","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"3472_CR203","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-14-122","volume":"14","author":"S Hattab","year":"2014","unstructured":"Hattab S, Guihot A, Guiguet M, Fourati S, Carcelain G, Caby F et al (2014) Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study. BMC Infect Dis 14(1):1\u20139","journal-title":"BMC Infect Dis"},{"key":"3472_CR204","doi-asserted-by":"crossref","unstructured":"Gold J, Rowe DB, Kiernan MC, Vucic S, Mathers S, van Eijk RP, et al (2019) Safety and tolerability of triumeq in amyotrophic lateral sclerosis: the lighthouse trial","DOI":"10.2139\/ssrn.3347916"},{"key":"3472_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117358","volume":"423","author":"M Garcia-Montojo","year":"2021","unstructured":"Garcia-Montojo M, Fathi S, Norato G, Smith B, Rowe D, Kiernan M et al (2021) Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy. J Neurol Sci 423:117358","journal-title":"J Neurol Sci"},{"key":"3472_CR206","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.msard.2018.06.002","volume":"24","author":"J Gold","year":"2018","unstructured":"Gold J, Marta M, Meier UC, Christensen T, Miller D, Altmann D et al (2018) A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study. Mult Scler Relat Disord 24:123\u2013128","journal-title":"Mult Scler Relat Disord"},{"issue":"9","key":"3472_CR207","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044099","volume":"7","author":"W Li","year":"2012","unstructured":"Li W, Jin Y, Prazak L, Hammell M, Dubnau J (2012) Transposable elements in TDP-43-mediated neurodegenerative disorders. PLoS One 7(9):e44099","journal-title":"PLoS One"},{"issue":"3","key":"3472_CR208","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006635","volume":"13","author":"L Krug","year":"2017","unstructured":"Krug L, Chatterjee N, Borges-Monroy R, Hearn S, Liao W-W, Morrill K et al (2017) Retrotransposon activation contributes to neurodegeneration in a drosophila TDP-43 model of ALS. PLoS Genet 13(3):e1006635","journal-title":"PLoS Genet"},{"key":"3472_CR209","doi-asserted-by":"crossref","unstructured":"Soares P, Silva C, Chavarria D, Silva FS, Oliveira PJ, Borges F (2022) Drug discovery and amyotrophic lateral sclerosis: emerging challenges and therapeutic opportunities. Ageing Res Rev 101790","DOI":"10.1016\/j.arr.2022.101790"},{"key":"3472_CR210","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2022.102229","volume":"211","author":"SS Keating","year":"2022","unstructured":"Keating SS, San Gil R, Swanson MEV, Scotter EL, Walker AK (2022) TDP-43 pathology: from noxious assembly to therapeutic removal. Prog Neurobiol 211:102229","journal-title":"Prog Neurobiol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03472-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03472-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03472-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T02:29:16Z","timestamp":1695781756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03472-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":210,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["3472"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03472-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,14]]},"assertion":[{"value":"12 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}